Clinical Trials
3 trialsNCT06651970 2026-05-18
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
Phase 4 Recruiting
NCT06256172 2024-02-13
Medlink
Olawuyi Racett Nigeria Ltd
Phase NA Completed
NCT06092606 2023-10-23
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
Monyan Pharmaceutical (Shanghai) Co., Ltd.
Phase 2 Unknown